Individual holder
SHAW GRAY D
US·6 granted patents·2 pending applications·10 citations·filing 2007–2022
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
8 records- 0192US12195518B2Methods for treating cancer using soluble forms of PSGL-1 and fusion molecules thereofSHAW GRAY D·Filed 2022·Granted Jan 14, 2025·1 cites·16 claims
- 0285US8889628B2Soluble tandem selectin glycoprotein ligand moleculesSHAW GRAY D·Filed 2012·Granted Nov 18, 2014·8 cites·12 claims
- 0373US10214578B1Variants of IgG-Fc fusion that provide for site-specific conjugation at the N-terminusSHAW GRAY D·Filed 2016·Granted Feb 26, 2019·1 cites·16 claims
- 0468US12479904B2Methods of treating cytokine release syndrome by administering a molecule comprising a soluble tandem selectin glycoprotein ligandSHAW GRAY D·Filed 2018·Granted Nov 25, 2025·0 cites·16 claims
- 0557US2007274999A1Method of treating disorders using platelet glycoprotein Ib alpha fusion polypeptidesSHAW GRAY D·Filed 2007·Application pending·0 cites
- 0654US2023303657A1Fusion Molecules of PSGL-1 or TSGL Anionic Domains to Checkpoint-Modulating Antibodies and Other AntibodiesSHAW GRAY D·Filed 2021·Application pending·0 cites
- 0747US10421796B2Variants of IgG Fc with limited amine groupsSHAW GRAY D·Filed 2015·Granted Sep 24, 2019·0 cites·7 claims
- 0841US9266923B2Compositions and methods for treatment of thrombosis and for prolonging survival of stored plateletsSHAW GRAY D·Filed 2011·Granted Feb 23, 2016·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when SHAW GRAY D files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →